The S&P/ASX 200 (ASX: XJO) finished flat on Thursday, but with growing dispersion in underlying company performance.
Treasury Wine Estates Ltd (ASX: TWE) led the way, jumping 17.5%, but it was healthcare company CSL Limited (ASX: CSL) that contributed most, with the consumer discretionary (+0.6%) and the healthcare (+2.0%) sectors the few winners.
Unemployment also continued to fall, down to 6.4%, after 30,000 new jobs were created. It was one of the busiest days of reporting season for larger companies, with two of Australia’s best-managed groups reporting.
Here’s a run-down of five big ASX reports from Thursday.
Wesfarmers delivers again
The first was Wesfarmers Ltd (ASX: WES), which finished 0.6% higher after reporting a 16.6% increase in revenue, with operating leverage sending net profit for the year up 25.5%.
The standout remains the Bunnings and Officeworks franchises, which saw sales increase 24.4% and 23.7% in the first half on 2019 levels, with the former remaining the key cash flow driver of the business. The pandemic forced Bunnings to finally embrace online sales, jumping 125% across the group in total, which has seen an expansion in profit margins.
Free cash flow improved 89% on the previous year, however, this included the acquisition of Kidman Resources and Catch Group. The dividend was increased by 17.3%, with the most powerful news being the decision to proceed with a $950 million investment into the Mt Holland Lithium project as the group pivots to the electric vehicle market.
CSL profits booming
CSL managed to overcome the headwind of a falling USD to deliver a 44% increase in profit to US$1.81 billion, announcing a record dividend, +9% to US$1.04 per share.
The result was driven by exceptionally strong growth in the influenza division, Seqirus, which reported a 38% increase in revenue. The core CSL Behring added 9% whilst the decision to change distribution channels into China is clearly paying off with sales of the Albumin treatment +93% on the prior period.
The company has overcome concerns of lower blood collections in the US, which were 80% of 2019 levels, and has managed to solidify its monopoly during the pandemic without profiting from the manufacture of a COVID-19 vaccine.
The long-awaited CSL112 treatment for cardiovascular diseases has also enrolled 11,500 patients into a Phase 3 trial in a positive step forward. This was another strong report from CSL, which now has an extensive pipeline of growth opportunities supported by a fast-growing but mature base. The CSL share price finished 2.8% higher.
Origin down but not out
Origin Energy Ltd (ASX: ORG) delivered a previously flagged 98% fall in profit, down from $599 million in the previous year. The weakness was not unexpected, driven by lower wholesale electricity prices due to weaker demand amid the pandemic along with lower oil and gas prices in its production and Energy Markets division.
The recent rally in the oil price is expected to feed into the second half of the year, with the price now around US$60 per barrel, offering a potential tailwind.
On the positive side, free cash flow was broadly in line with the previous year at $655 million with capital expenditure reduced, allowing a 12.5 cent per share dividend, down from 15 cents, equating to a 34% free cash flow payout. The company also flagged further progress on its hydrogen export projects, which stand out as a long-term growth opportunity.
As highlighted previously, the company offers a less leveraged exposure to the energy sector, being both a producer and generator able to extract profits at both levels. Origin shares fell 2.2% despite the negative sentiment. When compared to Woodside Petroleum Limited (ASX: WPL), which lost $4.0 billion in the half, the diversification is clear to see.
Fortescue delivers record dividend
Fortescue Metals Group Limited (ASX: FMG) became the third global iron ore company to deliver a record dividend this week, close to doubling its previous high to pay out US$1.47 per share.
The company reported a US$4.08 billion profit, 66% higher than 2019, on the back of a 44% increase in revenue to US$9.34 billion, putting on show its low cost, highly efficient business model.
After the earlier departures from its Iron Bridge development, the company reported a US$400 million cost blowout, but shares finished 1.9% in spite of the news.
ANZ halts dividend announcement
Finally, Australia and New Zealand Banking Group Ltd (ASX: ANZ) became the third bank to report this week, but the dividend announcement is still some time away. It was a positive result, with deferred home loans falling from $33 billion to just $6 billion and cash profit jumping significantly to $1.81 billion.
Despite concerns that low interest rates will impact on bank profits, it seems the RBA’s funding lines are keeping costs low and supporting significant loan growth. The ANZ share price finished 2.8% higher for the day.
Looking ahead, QBE Insurance Group Ltd (ASX: QBE), Cochlear Limited (ASX: COH), Cleanaway Waste Management Ltd (ASX: CWY) and Lovisa Holdings Ltd (ASX: LOV) are all set to report today. Be sure to bookmark Rask Media’s ASX reporting season hub for all the latest.